KPMG

Lawyers reviewing paperwork

Pharma

With arsenal of firepower, EY sees uptick in pharma M&A in 2024

In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity.

Kevin Dunleavy Jan 8, 2024 8:04am

Distributed data

Merck helps FDA test blockchain for track and trace

Jun 13, 2019 8:32am